initi coverag neutral rate believ
risk/reward remain balanc next month plu side huge fan
cgm believ place market implant version especi
highli accur one like eversens though lack reimburs mix physician
feedback make us question revenu ramp next month compani
excel manag team led well-respect diabet industri veteran tim
goodnow robust pipelin day sensor flash gemini version flash
day transmitt night said remain neutral hand hand combat
reimburs coverag current day configur initi
neutral pt base sale assum net cash
near term dynam near term expect compani get non-adjunct
label possibl mri indic well addit payer coverag also
expect updat deal roch could possibl extend ou market
though unsur econom number come
significantli fair view see ton upsid potenti
like like cgm categori expand dramat
last year long runway growth believ implant cgm
place market eversens sensor highli accur like
next icgm sensor also compani rich pipelin innov
flash sensor aka need wear transmitt bodi day sensor
gemini flash day transmitt night event
implant truli nake eye appeal us think diabet
patient well lastli docs/nurs make money everi procedur new
endocrinologist someth econom attract
dont like obviou requir mini procedur non-
starter patient heard feedback implant easi
remov trickier high volum endocrinologist minut
patient unsur fit case alreadi
busi routin also product broad base reimburs
expect win throughout yearthough time unknown
make revenu ramp uncertain final day sensor twice-
a-day calibr transmitt worn bodi competit libr
finger stick free opinion
reimburs coverage/pressur slower expect volum uptak
make implant continu glucos monitor diabet treatment
piper jaffray seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis report read conjunct import disclosur inform
includ attest regul analyst certif found page report follow site
page
today initi coverag senseon neutral rate think scienc behind
technolog quit remark highli accur cgm well-respect ceo
helm attract pipelin innov line howev believ revenu
ramp next month uncertain spotti reimburs coverag hope
improv throughout year time unknown view limit market
day sensor much interest us big fan cgm
market see rapid growth next sever year cgm becom standard care
type penetr type market unsur size implant market
time like pipelin flash product day sensor gemini flash
day transmitt night year away happen thu year
hope improv reimburs coverag follow day approv
remain neutral pt base sale assum
net cash fulli dilut share outstand
valuat current trade ev/sal compar diabet name trade
averag ev/sal stock inde recent high
valuat come quit bit said see materi upsid potenti
tndm sale well slight upsid podd estim less estim
time thu view multipl fair therefor believ stock properli valu
factset piper jaffray co estim price
manag ceo strong background diabet well respect
pipelin compani attract pipelin day sensor flash version
gemini flash day/transmitt night alert alarm
vibrat alert transmitt vibrat alert much discret
patient beep alarm vibrat also use alert peopl
flexibl patient take transmitt patient want
abl take break coupl hour beach go swim go date etc
abl take transmitt lose trend chart and/or requir new
sensor advantag
patient comfort/suit patch chang daili less adhes need
equat less potenti irrit longer sensor stay bodi stronger
adhes requir patient bad skin reaction adhes
therefor longer wear cgm sure exact percentag
know libr wors categori wouldnt surpris
number high patient experienc skin reaction sinc adhes
chang daili less chanc irrit
mri compat system may mri compat soon
page
factsetnot figur estimatesev/ebitdap/emarket cap consensusconsensu mil ev/sal
econom doc make money everi procedur tune
endocrinologist nurs ton procedur volum
someth new well receiv especi privat practic
procedur obviou sensor requir in-offic procedur done
oppos devic appli home hear insert easi
remov difficult
endocrinologist time averag endocrinologist get minut
patient fit sever eversens procedur day could challeng
reimburs product broad-bas reimburs unit
calibr devic still requir twice-a-day calibr world move
finger stick
relianc ou distribut compani depend roch rubin medic
drive ou sale total sale project
scar patient seem worri scar incis especi time
year multipl year could creat scar tissu time
physician europ use pocket elimin need anoth incis
put replac sensor though devic indic
sensor life failur libr sensor fail patient simpli request
new one replac eversens sensor fail patient would
new cgm replac procedur accord clinic trial
sensor last day precis trial last day precis ii
day trial precis last day last full day
canadian studi day show surviv day surviv
page
page
canadian studi day invest thesi
big fan cgm believ implant cgm place market cgm
set rapid growth next sever year expect benefit market
expans also one accur sensor market earli data would
indic good shot icgm big fan day sensor like
senss pipelin product particularli flash version sensor transmit directli
phone anyth truli invis aesthet reason also like pipelin product call
gemini flash day transmitt night alert alarm lastli
price right believ attract asset strateg want cgm play
addit cgm offer
cgm market set rapid growth big fan cgm market believ time
cgm replac bgm major type heavi insulin type play role
manag broader type within type cgm market penetr
combin type heavi insulin use type market
penetr market expand dramat demand driven dexcom
abbott cover freestyl libr cgm awar adopt grow
benefit accur sensor implant offer attract certain
patient segment exampl captur type eu market
would patient price would impli sale
price would equat sale compar project sale
nice runway growth
page
cgm market model million
implant aesthet pleas one main theme hear patient
want forget diabet want peopl know diabet
cure today technolog improv patient live go succeed
implant cgm like eversens better hidden on-the-bodi exampl
patient could take transmitt date put transmitt get home
lose sensor perform possibl libr unless
patient throw entir sensor put new one opinion make point even
advantag compani tri lose transmitt either turn devic
flash devic send sensor signal directli phone view would
highlight main benefit implant
accur sensor complianc payer like eversens sensor
accur mard compar dexcom freestyl libr
medtron guardian accord februari press releas
arm indic dont necessarili view mard appl appl given trial
design patient select trial believ eversens
system accur freestyl libr guardian sensor cgm less
accur day use minim sensor exampl day one
inaccuraci would happen time year day time year day
regular day sensor market would happen time lastli payer front
implant patient inher compliant sensor alway
said use transmitt look data improv clinic outcom
flip side payer could cover day suppli sensor abbott patient
could never open wear week stop therefor wast payer money
rich pipelin innov realli like compani pipelin believ hold
major valu longer term compani work day sensor requir
calibr per week opinion lot peopl will undergo
procedur per year oppos current time per year pipelin includ
on-demand flash version say type believ could actual
attract type market well libr built flash market made accept
altern favorit concept flash eversens truli invis world
would transmitt top skin patient would implant flash
want level lastli believ senss pipelin product call gemini
best world patient use flash day noth bodi
page
mdi normal cgm mdi insulin market invest risk
wear transmitt night alert alarm sleep still year away
next-up day approv earli think
best approach implant cgm technolog
implant place market attract asset believ
implant place market see percentag patient
interest implant version time like crux valu creation
earli feedback would suggest would athlet individu and/or one
issu adhes last day thu product eversens could
brought diabet organ exist salesforc effect cross sold
addit product offer note roch own compani alreadi pull
 insulin pump sale
believ place cgm market implant said unsur
much market share abl captur ramp us remain
uncertain given lack reimburs current day configur believ
time compani get reimburs come next year
day version believ that month away thu near term growth still
depend intern distributor growth choppi current renegoti
term well lastli price cgm come time compani need
smaller manufactur footprint competitor whose sensor last day still
cash burn posit tri expand gross margin neg gross margin
manag revenu ramp vs cgm price declin risk monitor
size implant market acknowledg place market
implant cgm though unsur today size slice exampl mani
patient would actual allow devic implant time year opinion minor
major view time year much wherea time year manag
year would best market implant devic option
contracept implant market share found kaiser famili
foundat women survey exhibit conduct research
implant med devic like glaukoss idos doctor suggest implant life least year
strong adopt therefor current day state unsur adopt ramp
page
price cgm come time outlin larger cgm note releas
august see note price cgm come time effect replac
bgm market senss current price day price rang time price come
per day uniqu posit get day approv
implant per year per patient oppos abbott need much larger scale
manufactur approxim sensor year said earli revenu
ramp could prove challeng smaller compani cash burn phase growth
exampl grow nice take asp headwind
volum infrastructur balanc sheet handl libr
eventu cover pharmaci benefit lower pocket cost
patient like fit dme coverag medic benefit latter much
attract former
reimburs coverag adopt med tech franchis reimburs
coverag today age fda approv one thing get payer board whole
challeng said cgm categori total new clinic benefit
clinic data continu build categori whole note
implant version impli complianc aspect attract
payer current coverag aetna cross shield minnesota
horizon new jersey well smaller payer aetna reimburs
tradit cgm code top physician code insert remov
devic cgm aspect would cover dme wherea would
medic benefit cross shield minnesota horizon new jersey bundl cgm
compon procedur togeth one payment bundl payment fall
patient medic benefit bundl option would prefer requir less
paperwork easier parti involv view year coverag
updat make break trajectori busi near term physician
reluct offer eversens know cover mani cash pay
patient reimburs coverag key long-term valu creation expect
stock trade around posit neg updat come note plan follow
medicar get non-adjunct claim come soon import get medicar
intern distributor control ou destini today outsid senss growth
depend distributor rubin medic scandinavia roch throughout rest
europ middl east africa current sell countri gener roch
done lot heavi lift roch distribut agreement set expir
decemb sinc extend januari feel agreement
benefici parti discuss around expand agreement new countri
econom thu roch want take eversens countri would want
better price return common smaller mid-siz med tech
compani util distributor ou compani focus grow market
produc lumpi result time make difficult provid guidanc
depend inform anoth parti differ ou
revenu account sale today theyr depend distributor vs
med tech compani start good base expand
regulatori day icgm januari start promis
trial approv trial hope get icgm design well
view get day sensor wear eventu day sensor wear key adopt
hiccup trial would view neg assum enrol next month
page
expect data/approv first half accur sensor shown
exhibit day sensor would qualifi icgm recogn
data appl appl report tabl differ bracket mg/dl
vs icgm bracket sub interpret data howev day sensor look
hit accuraci standard though recogn studi power properli
point accuraci vs lower bound data day
precis trial hit icgm standard -- miss read low middl
overal rang devic though hit high rang data canada
day hit overal rang seen metric high/low
time said compani made improv sinc precis trial
manag seem confid capabl get icgm design
page
page
lower point precis point day precis point day precis ii point day canada studi point day robust clinic data demonstr accuraci devic intend use popul ii clinic data must includ comparison icgm valu blood glucos valu inspecimen collect parallel measur fda-accept laboratory-bas glucos measur method precis accur traceabl higher order intern recogn refer materi and/or method iii clinic data must obtain clinic studi design fulli repres perform ofth devic throughout intend use popul throughout measur rang devic iv clinic studi result must demonstr consist analyt clinic perform throughout thesensor wear period clinic studi result adult popul must meet follow perform requir icgm measur less mg/dl percentag icgm measur within mg/dl correspond blood glucos valu must calcul lower one-sid confid bound must exceed icgm measur mg/dl percentag icgm measur within correspond blood glucos valu must calcul lower one-sid confid bound must exceed icgm measur greater mg/dl percentag icgm measur within /- correspond blood glucos valu must calcul lower one-sid confid bound must exceed icgm measur less mg/dl percentag icgm measur within mg/dl correspond blood glucos valu must calcul lower one-sid confid bound must exceed icgm measur mg/dl percentag icgm measur within ofth correspond blood glucos valu must calcul lower one-sid confid bound must exceed icgm measur greater mg/dl percentag icgm measur within /- correspond blood glucos valu must calcul lower one-sid confid bound must exceed throughout devic measur rang percentag icgm measur within /- correspond blood glucos valu must calcul lower one-sid confid bound must exceed icgm valu less mg/dl correspond blood glucos valu shall read icgm valu greater mg/dl correspond blood glucos valu shall read less shall icgm measur indic posit glucos rate chang greater mg/dl/min correspond true neg glucos rate chang less mg/dl/min determin correspond blood glucos shall icgm measur indic neg glucos rate chang less mg/dl/min correspond true posit glucos rate chang greater mg/dl/min determin correspond blood glucos data demonstr similar accuraci rate chang perform icgm pediatricpopul compar adult popul altern clinic and/or technic justif pediatr data need must provid determin fda accept appropri vii data must demonstr throughout claim sensor life devic allow clinic signific gap sensor data avail would prevent digit connect devic achiev intend design verif valid must includ detail strategi ensur secur reliabl mean oficgm data transmiss provid real-tim glucos read clinic meaning time interv devic intend receiv icgm glucos design verif valid must includ adequ control establish manufactur andat product releas ensur releas product meet perform specif defin paragraph devic must demonstr clinic accept perform presenc clinicallyrelev level potenti interf substanc reason present intend use popul includ limit endogen substanc metabolit food dietari supplement devic must includ appropri measur ensur dispos sensor use beyond claim sensor wear design verif valid must includ result obtain usabl studi thatdemonstr intend user use devic safe obtain expect glucos measur label must includ separ descript follow sensorperform data observ clinic studi perform conform paragraph intend use popul addit separ sensor perform data differ icgm insert use site abdomen arm buttock
world first implant cgm call eversens cgm better known
continu glucos monitor read person blood glucos level everi minut
oppos patient use blood glucos monitor finger prick multipl time
day eversens day version eversens xl day version
approv europ time expect
market like freestyl libr guardian connect skin needl
enter bodi oppos eversens fulli implant
exhibit show compon system compris sensor
small size headphon connector transmitt mobil app
sensor state sensor small elut drug call
dexamethason acet anti-inflammatori drug reason dexamethason
acet bodi encapsul devic foreign object bodi
senor continu provid accur glucos read sensor one
accur sensor market behind dexcom view insert procedur
quick take minut local anesthet doctor nurs practition
physician assist easili procedur one clinician favorit thing
get reimburs mini procedur look patient blog
whole procedur seem rel easi pain free insert sensor need
hour warm-up period provid glucos read final period
day europ sensor remov new pocket usual opposit arm
creat next sensor implant heard explant devic much
harder implant tricki grasp fish earli day launch
believ take practic
page
transmitt smart transmitt worn sensor via bluetooth take
read sensor transmit mobil devic transmitt attach via
patch acryl adhes side attach back smart transmitt
silicon adhes side attach skin adhes patch chang daili
requir less adhes compar devic need stay bodi day
result less irrit compar other gener unlik market
transmitt taken patient like aspect go swim shower play
contact sport sensor could get bump even read blog patient
take special occas like wed wear specif cloth
show world sensor batteri transmitt last
hour take approxim minut recharg
page
phone app lastli phone app heard mix review like
believ could better opinion depend use whether
new cgm came dexcom/libr app view necessari
function importantli share function friends/famili member
view patient glucos level like compani space expect improv
app function time
page
yet see number project year solid progress
top-line perspect deliv growth small base bulk revenu
came ou partnership roch rubin medic estim revenu
ou platform launch unit state go
forward basi model revenu growth account approxim
total revenu growth revenu us estim mix
transmitt sensor european patient growth transit
sensor-bas revenu stream consist manag comment expect year-
end patient count approxim patient unit state estim
ou expect year end number impli patient growth
 growth ou third full year commerci
model growth growth revenu ou
respect assum slight price pressur transmitt side
compani pursu new geographi
page
requir lower cost devic sensor side assum averag sensor asp per
day per day ramp blend reorder rate
patient popul transit season group
recal attrit first sensor less follow second sensor
unit state expect growth growth revenu
respect assum less price pressur compani
launch domest accordingli hold transmitt sensor
subsequ year use higher attrit rate us compar
ou larger percentag patient come on-line first purchas
us year patient add expect non-linear us compani
ramp salesforc expect therefor assum
sale occur back half year
gross margin front project begin achiev posit gross margin
project gm compar project
compani said expect gross margin europ
unit state break-even project occur wildcard situat
revis agreement roch term econom oper perspect
model steadi declin expens percent sale initi launch cost fade sale
market expens declin
realiz effici experienc salesforc expens cut half yearli
basi compani move toward sale org clinic stage devic develop
addit forecast declin percent sale
end cash cash equival balanc sheet
follow three capit rais issu convert note januari
issu share total march june long-term debt total
end though account convert mention
option transit equiti convers rate share per
princip approxim per share stock given amount cash balanc
sheet forese need issu addit equiti next year
rate ow pt base sale assum net cash
fulli dilut share outstand risk includ regulatori approv competit product
rate ow pt base cy ep risk includ
slowdown key market competit pressur regulatori delay
rate ow pt base ev/revenu assum
net debt share outstand risk includ regulatori delay establish competit
global insulin deliveri market
rate ow pt base sale estim assum
net cash s/o risk includ competit reimburs regulatori delay
rate pt risk
page
thousand except per share data
sale
sale market
gener administr
incom tax
provis tax
percent sale
current disclosur inform compani locat http //www piperjaffray com/researchdisclosur
